REGN FY 2007 Earnings — Regeneron Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

REGNRegeneron Pharmaceuticals, Inc.

$78B

FY 2007 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$125M+97.1% YoY

Gross Profit

$00.0% margin

Operating Income

-$114M-91.5% margin

Net Income

-$106M-84.5% margin

EPS (Diluted)

$-1.59

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

$9M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$936M

Total Liabilities

$476M

Stockholders' Equity

$460M

Cash & Equivalents

$499M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$125M	$63M	+97.1%
Gross Profit	$0	$41M	-100.0%
Operating Income	-$114M	-$107M	-6.7%
Net Income	-$106M	-$102M	-3.2%